SBFM FY 2021 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$228,426+219.9% YoY

Gross Profit

$110,59648.4% margin

Operating Income

-$2M-1068.2% margin

Net Income

-$12M-5444.2% margin

EPS (Diluted)

$-9520.00

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$918,000

Balance Sheet

Total Assets

$2M

Total Liabilities

$2M

Stockholders' Equity

$211,662

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228,426	$71,410	+219.9%
Gross Profit	$110,596	$45,563	+142.7%
Operating Income	-$2M	-$576,874	-323.0%
Net Income	-$12M	-$3M	-346.7%